Reference
Correll CK, et al. Safety and clinical response of weekly adalimumab in the treatment of juvenile idiopathic arthritis, pediatric chronic uveitis and other childhood rheumatic diseases. Arthritis and Rheumatology 68 (Suppl. S10): 501-504, Oct 2016. Available from: URL: http://doi.org/10.1002/art.39977 [abstract] - USA
Rights and permissions
About this article
Cite this article
Adalimumab. Reactions Weekly 1635, 21 (2017). https://doi.org/10.1007/s40278-017-25270-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-25270-3